ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Meeting Set For Oct. 3-5; Second Workshop On Tumor Cell Cloning Jan. 3-5

August 24, 1979

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997